David Charles Bosanquet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Charles Bosanquet has a total of 279 co-authors. Here are the top co-authors by number of shared publications:
- Christopher P. Twine
North Bristol NHS Trust and University of Bristol, Bristol, UK
19 shared publications - Graeme Keith Ambler
Cambridge Vascular Unit, Cambridge University Hospitals NHS Trust, Cambridge, UK; Centre for Surgical Research, University of Bristol, Bristol, UK
12 shared publications - James Glasbey
NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK
7 shared publications - Keith Gordon Harding
Cardiff University Cardiff UK
7 shared publications - Brenig Llwyd Gwilym
South East Wales Vascular Network, Cardiff, UK
6 shared publications - Cherry-Ann Waldron
Centre for Trials Research, Cardiff University School of Medicine, Cardiff, Cardiff, UK
6 shared publications
Latest Publications
- 2 October 2026
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 35 (10) , 901-914
Intermittent pneumatic thigh compression for the treatment of lower limb wounds (IPCOTT): a randomised control trial
Objective: Hard-to-heal (chronic) venous leg ulcers (VLUs) are challenging to heal with standard of care (SoC) alone. This study evaluated whether adding a thigh-administered intermittent pneumatic compression (IPC) device (WoundExpress, Huntleigh Healthcare Ltd., UK) to SoC improved outcomes in patients with hard-to-heal venous or mixed leg ulcers (venous and arterial), was suitable for home use and was safe. Method: A multicentre, pragmatic, open-label, randomised controlled trial (RCT) was conducted across the UK, US, Germany and France. Adults with hard-to-heal lower limb VLUs and mixed ulcers already receiving compression were randomised 1:1 to adjunctive IPC (two hours/day; intervention) plus SoC, or SoC alone (control), for 16 weeks. The primary outcome was percentage change in wound area. Secondary outcomes included: complete healing; wound pain; quality of life (QoL); acceptability; usage; and safety. Results: A total of 136 patients were randomised (n=65 IPC; n=71 control); 116 patients completed the study. Median wound area reduction at 16 weeks was similar: (intervention: 64.0% versus control: 67.7%; p=0.35). Complete healing occurred in 16.9% (IPC) and 18.3% (control) patients (p=0.80). Pain scores and QoL improved modestly in both groups, with no between-group differences. The IPC device was well tolerated: 64% of patients rated it ‘very good’ or ‘excellent’. Mean use was ~2.0 hours/day, as reported in patient diaries. Adverse events were primarily mild and comparable (54% IPC; 59% control); only one mild event was device-related. Conclusion: In this RCT, thigh-administered IPC did not improve healing beyond SoC in this patient population, although it was safe, well-tolerated, and feasible for home use.
- 2 October 2026
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 35 (10) , 901-914
Intermittent pneumatic thigh compression for the treatment of lower limb wounds (IPCOTT): a randomised control trial
Objective: Hard-to-heal (chronic) venous leg ulcers (VLUs) are challenging to heal with standard of care (SoC) alone. This study evaluated whether adding a thigh-administered intermittent pneumatic compression (IPC) device (WoundExpress, Huntleigh Healthcare Ltd., UK) to SoC improved outcomes in patients with hard-to-heal venous or mixed leg ulcers (venous and arterial), was suitable for home use and was safe. Method: A multicentre, pragmatic, open-label, randomised controlled trial (RCT) was conducted across the UK, US, Germany and France. Adults with hard-to-heal lower limb VLUs and mixed ulcers already receiving compression were randomised 1:1 to adjunctive IPC (two hours/day; intervention) plus SoC, or SoC alone (control), for 16 weeks. The primary outcome was percentage change in wound area. Secondary outcomes included: complete healing; wound pain; quality of life (QoL); acceptability; usage; and safety. Results: A total of 136 patients were randomised (n=65 IPC; n=71 control); 116 patients completed the study. Median wound area reduction at 16 weeks was similar: (intervention: 64.0% versus control: 67.7%; p=0.35). Complete healing occurred in 16.9% (IPC) and 18.3% (control) patients (p=0.80). Pain scores and QoL improved modestly in both groups, with no between-group differences. The IPC device was well tolerated: 64% of patients rated it ‘very good’ or ‘excellent’. Mean use was ~2.0 hours/day, as reported in patient diaries. Adverse events were primarily mild and comparable (54% IPC; 59% control); only one mild event was device-related. Conclusion: In this RCT, thigh-administered IPC did not improve healing beyond SoC in this patient population, although it was safe, well-tolerated, and feasible for home use.
- Open Access
- 17 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (5) , 664-674
Peri‐operative pain management in major lower extremity amputation in vascular Surgery: a UK anaesthetic and vascular surgery Delphi consensus study*
Summary: Introduction: Major lower extremity amputations occurring secondary to vascular disease remain prevalent worldwide. Pain surrounding these procedures is complex, multifactorial and associated with poor functional and psychosocial outcomes. The evidence base informing pain management approaches in major lower extremity amputations remain largely heterogeneous and limited. This study aimed to establish procedure‐specific, multispeciality consensus on the ideal principles and practices required to optimise pain management for vascular surgical patients undergoing major lower extremity amputations. Methods: A three‐round online modified Delphi consensus process was undertaken, with consultant anaesthetists and consultant vascular surgeons across the UK forming the expert panel. Structured statements were assessed on a 5‐point Likert scale against a strong consensus threshold of ≥ 75% ratings in agreement or disagreement, and a rating stability criterion of < 10% change between rounds. Free‐text responses were thematically analysed at each round to iteratively modify or generate new statements. Results: Seventy‐two panellists participated in the study. Of the 44 consensus statements assessed, 32 reached strong consensus agreement. These included: shared cross‐speciality responsibility for pain management; the mainstay role of locoregional analgesia; use of perineural catheters; opioid‐sparing approaches; and protocolised decision aids with individualisation of analgesia. Barriers to practices identified included resource constraints and the paucity of direct evidence. There was non‐consensus in 12 statements, notably on pre‐amputation initiation of locoregional analgesia; ultrasound‐guided nerve catheter placement; and surgeon‐delivered regional analgesia. No statement reached strong consensus disagreement. Discussion: This study provides the first procedure‐specific consensus, delineating agreed principles and preferred pharmacological and locoregional analgesic approaches to peri‐operative pain management in patients undergoing major lower extremity amputations. The areas of non‐consensus expose key uncertainties that may inform future research, service organisation and guideline development agendas.
- 17 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (5) , 664-674
Open AccessPeri‐operative pain management in major lower extremity amputation in vascular Surgery: a UK anaesthetic and vascular surgery Delphi consensus study*
Summary: Introduction: Major lower extremity amputations occurring secondary to vascular disease remain prevalent worldwide. Pain surrounding these procedures is complex, multifactorial and associated with poor functional and psychosocial outcomes. The evidence base informing pain management approaches in major lower extremity amputations remain largely heterogeneous and limited. This study aimed to establish procedure‐specific, multispeciality consensus on the ideal principles and practices required to optimise pain management for vascular surgical patients undergoing major lower extremity amputations. Methods: A three‐round online modified Delphi consensus process was undertaken, with consultant anaesthetists and consultant vascular surgeons across the UK forming the expert panel. Structured statements were assessed on a 5‐point Likert scale against a strong consensus threshold of ≥ 75% ratings in agreement or disagreement, and a rating stability criterion of < 10% change between rounds. Free‐text responses were thematically analysed at each round to iteratively modify or generate new statements. Results: Seventy‐two panellists participated in the study. Of the 44 consensus statements assessed, 32 reached strong consensus agreement. These included: shared cross‐speciality responsibility for pain management; the mainstay role of locoregional analgesia; use of perineural catheters; opioid‐sparing approaches; and protocolised decision aids with individualisation of analgesia. Barriers to practices identified included resource constraints and the paucity of direct evidence. There was non‐consensus in 12 statements, notably on pre‐amputation initiation of locoregional analgesia; ultrasound‐guided nerve catheter placement; and surgeon‐delivered regional analgesia. No statement reached strong consensus disagreement. Discussion: This study provides the first procedure‐specific consensus, delineating agreed principles and preferred pharmacological and locoregional analgesic approaches to peri‐operative pain management in patients undergoing major lower extremity amputations. The areas of non‐consensus expose key uncertainties that may inform future research, service organisation and guideline development agendas.
- 30 July 2025
- Published by SAGE Publications in Vascular
- Vol. 34 (3) , 612-619
Can BlueDop be used as an alternative for diagnosing peripheral arterial disease? A prospective comparison of traditional ABPI and TBPI with BlueDop
Objectives: Ankle and toe brachial pressure index are recommended globally as first line non-invasive screening tests for peripheral arterial disease. However, they can be inaccurate and have limited utility in patients with incompressible arteries, lower limb wounds and/or lack of digits. This study aims to evaluate BlueDop, a novel device that purports to assess peripheral perfusion without the need for a lower limb tourniquet or patients lying flat. Methods: Patients attending vascular and podiatry clinic at Aneurin Bevan University Health Board were recruited between May 2022 and May 2023. A BlueDop reading was recorded in addition to ankle and/or toe brachial pressure index. Satisfaction and preference of each method was recorded using an electronic proforma. Results: 176 patients were included. BlueDop ABPI was shown to be moderately correlated with cuff-ABPI (r s = 0.42, p = .001) and weakly correlated with TBPI (r s = 0.22, p = .04). BlueDop had moderate accuracy in diagnosing PAD (C statistic = 0.653) and was more accurate in diagnosing severe PAD (C statistic = 0.706). Diagnostic accuracy appeared to be improved when PAD was defined according to cuff-ABPI only. Patients were more satisfied with BlueDop (mean satisfaction score (MSS) = 4.33) compared to cuff-ABPI (MSS = 2.89, mean difference = 0.544, p < .001) and TBPI (MSS = 3.82, mean difference = 0.579, p < .001) while operator satisfaction was equal. Conclusions: There is moderate correlation between BlueDop and cuff-ABPI. Patients prefer BlueDop to cuff-ABPI or TBPI. BlueDop appears to be an acceptable method of non-invasive assessment of PAD, although users must appreciate there is a discrepancy between it and cuff-ABPI/TBPI.
- 30 July 2025
- Published by SAGE Publications in Vascular
- Vol. 34 (3) , 612-619
Can BlueDop be used as an alternative for diagnosing peripheral arterial disease? A prospective comparison of traditional ABPI and TBPI with BlueDop
Objectives: Ankle and toe brachial pressure index are recommended globally as first line non-invasive screening tests for peripheral arterial disease. However, they can be inaccurate and have limited utility in patients with incompressible arteries, lower limb wounds and/or lack of digits. This study aims to evaluate BlueDop, a novel device that purports to assess peripheral perfusion without the need for a lower limb tourniquet or patients lying flat. Methods: Patients attending vascular and podiatry clinic at Aneurin Bevan University Health Board were recruited between May 2022 and May 2023. A BlueDop reading was recorded in addition to ankle and/or toe brachial pressure index. Satisfaction and preference of each method was recorded using an electronic proforma. Results: 176 patients were included. BlueDop ABPI was shown to be moderately correlated with cuff-ABPI (r s = 0.42, p = .001) and weakly correlated with TBPI (r s = 0.22, p = .04). BlueDop had moderate accuracy in diagnosing PAD (C statistic = 0.653) and was more accurate in diagnosing severe PAD (C statistic = 0.706). Diagnostic accuracy appeared to be improved when PAD was defined according to cuff-ABPI only. Patients were more satisfied with BlueDop (mean satisfaction score (MSS) = 4.33) compared to cuff-ABPI (MSS = 2.89, mean difference = 0.544, p < .001) and TBPI (MSS = 3.82, mean difference = 0.579, p < .001) while operator satisfaction was equal. Conclusions: There is moderate correlation between BlueDop and cuff-ABPI. Patients prefer BlueDop to cuff-ABPI or TBPI. BlueDop appears to be an acceptable method of non-invasive assessment of PAD, although users must appreciate there is a discrepancy between it and cuff-ABPI/TBPI.
- 15 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (6) , 763-764
Vascular Surgeons and Abdominal Aortic Aneurysm Repair Threshold Guidelines: Compliance or Defiance?
- 15 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (6) , 763-764
Vascular Surgeons and Abdominal Aortic Aneurysm Repair Threshold Guidelines: Compliance or Defiance?
- 18 June 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 480-481
Ultrasound Guidance for Supporting Vascular Closure Devices: A Sound Decision?
- 18 June 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (4) , 480-481
Ultrasound Guidance for Supporting Vascular Closure Devices: A Sound Decision?
- 17 September 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (6) , 759-769
Impact of Tourniquet Use in Major Lower Limb Amputation: A Systematic Review and Meta-analysis
- 17 September 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (6) , 759-769
Impact of Tourniquet Use in Major Lower Limb Amputation: A Systematic Review and Meta-analysis
- 8 August 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (5) , 629-630
Human Hepatocyte Growth Factor for Chronic Limb Threatening Ischaemia: Does It Deliver?
- 8 August 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (5) , 629-630
Human Hepatocyte Growth Factor for Chronic Limb Threatening Ischaemia: Does It Deliver?
- 3 August 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (5) , 652-653
Amputation Surgery: Not Very Trendy
- 3 August 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 68 (5) , 652-653
Amputation Surgery: Not Very Trendy
- Open Access
- 3 July 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (7) , e14946
The incidence of surgical site infection following major lower limb amputation: A systematic review
Surgical site infections (SSIs) following major lower limb amputation (MLLA) in vascular patients are a major source of morbidity. The objective of this systematic review was to determine the incidence of SSI following MLLA in vascular patients. This review was prospectively registered with the International Prospective Register of Systematic Reviews (CRD42023460645). Databases were searched without date restriction using a pre‐defined search strategy. The search identified 1427 articles. Four RCTs and 21 observational studies, reporting on 50 370 MLLAs, were included. Overall SSI incidence per MLLA incision was 7.2% (3628/50370). The incidence of SSI in patients undergoing through‐knee amputation (12.9%) and below‐knee amputation (7.5%) was higher than the incidence of SSI in patients undergoing above‐knee amputation, (3.9%), p < 0.001. The incidence of SSI in studies focusing on patients with peripheral arterial disease (PAD), diabetes or including patients with both was 8.9%, 6.8% and 7.2%, respectively. SSI is a common complication following MLLA in vascular patients. There is a higher incidence of SSI associated with more distal amputation levels. The reported SSI incidence is similar between patients with underlying PAD and diabetes. Further studies are needed to understand the exact incidence of SSI in vascular patients and the factors which influence this.
- 3 July 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (7) , e14946
Open AccessThe incidence of surgical site infection following major lower limb amputation: A systematic review
Surgical site infections (SSIs) following major lower limb amputation (MLLA) in vascular patients are a major source of morbidity. The objective of this systematic review was to determine the incidence of SSI following MLLA in vascular patients. This review was prospectively registered with the International Prospective Register of Systematic Reviews (CRD42023460645). Databases were searched without date restriction using a pre‐defined search strategy. The search identified 1427 articles. Four RCTs and 21 observational studies, reporting on 50 370 MLLAs, were included. Overall SSI incidence per MLLA incision was 7.2% (3628/50370). The incidence of SSI in patients undergoing through‐knee amputation (12.9%) and below‐knee amputation (7.5%) was higher than the incidence of SSI in patients undergoing above‐knee amputation, (3.9%), p < 0.001. The incidence of SSI in studies focusing on patients with peripheral arterial disease (PAD), diabetes or including patients with both was 8.9%, 6.8% and 7.2%, respectively. SSI is a common complication following MLLA in vascular patients. There is a higher incidence of SSI associated with more distal amputation levels. The reported SSI incidence is similar between patients with underlying PAD and diabetes. Further studies are needed to understand the exact incidence of SSI in vascular patients and the factors which influence this.